Disruptive technology risks could threaten Illumina's industry-leading sequencing platform, leading to market share losses and profit declines. A significant portion of Illumina’s growth will ...

John West, general manager of Illumina's DNA sequencing business unit and Kevin McKernan, an inventor of the Applied Biosystem's SOLiD System technology, both say their companies are playing with ...

Disruptive technology risks could threaten Illumina's industry-leading sequencing platform, leading to market share losses and profit declines. A significant portion of Illumina’s growth will ...

with Illumina's proven and highly scalable sequencing technology, the partnership aims to deliver innovative solutions to researchers and breeders in the As Illumina, Inc. (NASDAQ: ILMN), a global ...

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced that it will present updates on several key innovations in whole-genome sequencing, proteomics, and ...

Meanwhile, in the second quarter of 2024, GRAIL’s multi-cancer early detection test, Galleri, enabled by Illumina’s sequencing technology, drove a 32% increase in the GRAIL Service and other ...

During the meeting, Steve Barnard, PhD, Illumina’s CTO will provide new details about the company’s constellation mapped read technology. He will be joined by Niall Lennon, PhD, chair and CSO ...

The Invitrogen Collibri DNA Library Prep Kits prepare libraries for whole-genome sequencing (WGS) on Illumina NGS systems and contain tracking dyes to quickly and easily visualize library prep ...

New, groundbreaking technology delivers Illumina's most comprehensive genome yet; early results from Broad Clinical Labs demonstrate a highly simplified workflow, ultra-long phasing, high ...

This collaboration will be the first relating to the development of Illumina's novel molecular residual disease (MRD) assay, a whole-genome sequencing ... of our unique MRD technology and the ...